menu ☰
menu ˟

Indian generics manufacturer Ranbaxy agrees to pay $500m to settle US fraud and drug safety charges

30 May 2013

Generic drug manufacturer Ranbaxy has agreed to pay a fine of $500m (£330m; €385m) to settle US government charges of fraud at two of its Indian factories, which came to light eight years ago. The...

Date: 
30 May 2013

Click here to view the full article which appeared in British Medical Journal (BMJ)